Mucosal vaccination against bacterial respiratory infections
- PMID: 18844598
- DOI: 10.1586/14760584.7.8.1257
Mucosal vaccination against bacterial respiratory infections
Abstract
Mucosal vaccination offers attractive advantages to conventional systemic vaccination, such as higher levels of antibodies and protection at the airway surface. This review gives an overview of recent experimental and clinical data on nasal, oral and sublingual vaccines against bacterial respiratory pathogens, such as Streptococcus pneumoniae , Haemophilus influenzae , Neisseria meningitidis , Moraxella catarrhalis , Bordetella pertussis , Pseudomonas aeruginosa and Mycobacterium tuberculosis . Subsequently, we discuss further vaccine development that opens the focus to clinical use.
Similar articles
-
Intranasal vaccines for protection against respiratory and systemic bacterial infections.Expert Rev Vaccines. 2007 Jun;6(3):419-29. doi: 10.1586/14760584.6.3.419. Expert Rev Vaccines. 2007. PMID: 17542756 Review.
-
Mucosal immunization against respiratory bacterial pathogens.Expert Rev Vaccines. 2003 Aug;2(4):551-60. doi: 10.1586/14760584.2.4.551. Expert Rev Vaccines. 2003. PMID: 14711339 Review.
-
[Oral administration of "Infectvac" for prevention of acute respiratory tract infections].Z Erkr Atmungsorgane. 1990;175(2):95-9. Z Erkr Atmungsorgane. 1990. PMID: 2264367 German.
-
Mucosal vaccines: novel advances in technology and delivery.Expert Rev Vaccines. 2009 Aug;8(8):1083-97. doi: 10.1586/erv.09.61. Expert Rev Vaccines. 2009. PMID: 19627189 Review.
-
[Assessment of salivary IgA titer in children with recurrent respiratory infections treated with polyvalent oral vaccine. A controlled study].Minerva Pediatr. 1988 Jun;40(6):355-60. Minerva Pediatr. 1988. PMID: 3054472 Clinical Trial. Italian. No abstract available.
Cited by
-
Survey of Omp19 immunogenicity against Brucella abortus and Brucella melitensis: influence of nanoparticulation versus traditional immunization.Vet Res Commun. 2015 Dec;39(4):217-28. doi: 10.1007/s11259-015-9645-2. Epub 2015 Sep 22. Vet Res Commun. 2015. PMID: 26395469
-
A foreign protein incorporated on the Tip of T3 pili in Lactococcus lactis elicits systemic and mucosal immunity.Infect Immun. 2010 Mar;78(3):1294-303. doi: 10.1128/IAI.01037-09. Epub 2009 Dec 22. Infect Immun. 2010. PMID: 20028807 Free PMC article.
-
Oral immunization of mice with Omp31-loaded N-trimethyl chitosan nanoparticles induces high protection against Brucella melitensis infection.Int J Nanomedicine. 2017 Dec 13;12:8769-8778. doi: 10.2147/IJN.S149774. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29263667 Free PMC article.
-
Quantity and Quality of Inhaled Dose Predicts Immunopathology in Tuberculosis.Front Immunol. 2015 Jun 29;6:313. doi: 10.3389/fimmu.2015.00313. eCollection 2015. Front Immunol. 2015. PMID: 26175730 Free PMC article. Review.
-
Enhanced antigen uptake by dendritic cells induced by the B pentamer of the type II heat-labile enterotoxin LT-IIa requires engagement of TLR2.Vaccine. 2010 May 7;28(21):3696-705. doi: 10.1016/j.vaccine.2010.03.016. Epub 2010 Mar 21. Vaccine. 2010. PMID: 20332049 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical